Predictors of chronic arthralgia after chikungunya virus infection: a systematic review and meta-analysis

Clicks: 12
ID: 326594
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #29 of 58 articles by views in international journal of travel medicine and global health

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
ABSTRACT Background Chikungunya is an expanding global health threat, with chronic arthralgia representing the main long-term driver of disability. Although many studies have assessed post-chikungunya outcomes, evidence remains fragmented and contradictory. We aimed to identify reproducible predictors of chronic arthralgia (≥3 months) after laboratory-confirmed chikungunya and to distinguish stable prognostic signals from context-dependent associations. Methods We searched PubMed, Embase, Cochrane Library, and BVS/LILACS from inception to Feb 6, 2026, without restrictions. Eligible studies compared participants with and without chronic arthralgia at follow-up and reported extractable baseline or acute-phase factors. Two reviewers independently screened records, extracted data, and assessed risk of bias using QUIPS. Random-effects restricted maximum likelihood meta-analyses pooled odds ratios and mean differences, with subgroup analyses by follow-up window. PROSPERO: CRD420251169320. Results Of 1784 records, 29 studies were included, comprising 4108 participants: 1838 with chronic arthralgia and 2230 without. After harmonization, 22 predictors were meta-analyzed. The most consistent associations were female sex (OR 2.08, 95% CI 1.77–2.46; I2=8.3%), comorbidity presence (1.99, 1.55–2.55; I2=0%), and high blood pressure (1.52, 1.13–2.04; I2=33.4%). In contrast, several acute-phase manifestations and treatment-related markers showed less stable, timing-dependent, or study-sensitive associations. Overall risk of bias was high in most studies and moderate in the remainder. Conclusions Chronic post-chikungunya arthralgia was most reproducibly associated with readily identifiable baseline host factors, rather than with a uniform acute-severity phenotype. These findings suggest that risk stratification should not rely only on acute symptom burden, and that pre-existing vulnerability may define a clinically important high-risk group. Point-of-care identification of patients with these characteristics could support prioritization of follow-up and resource allocation during outbreaks, inform post-outbreak surveillance and guideline development, and may guide future burden-based vaccination strategies in endemic settings.
Reference Key
openalex_W7204554623 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lucas B C C Kotecki, Vitória Demarque Medeiros, Mariana B C C Kotecki, Bianca Gabriela T Castiglioni, M Lenzi, Isadora P Silva, Rafaela Coelho Duarte, João Vitor K Souza, Cláudia F N S Santos, Gabriela Stutz F. Moreira, José A Kotecki, Lucas P Salomão, Tatiana F Oliveira
Journal international journal of travel medicine and global health
Year 2026
DOI
10.1093/jtm/taag078
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.